Trenton Kinnear, MD
Vascular Surgery · Oklahoma City, OKNPI 1538540935
Payments from drug & device makers
What this record shows
This record is dominated by grants: $6,500 of the $9,969 with a category attached, or 65.2%. Medtronic accounts for 79.2% of it on its own, with 14 other manufacturers making up the rest.
Across 57 payments — averaging $174.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- W. L. Gore & Associates, Inc.$964
- Silk Road Medical, Inc.$299
- Penumbra, Inc.$160
- Boston Scientific$141
- Abiomed$121
- plus $385 from 9 others
What the payments were for
- Grants$6,50065%
- Travel & lodging$3924%
- Food & beverage$3,07731%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 26 | $7,900 |
| W. L. Gore & Associates, Inc. | 9 | $964 |
| Silk Road Medical, Inc. | 2 | $299 |
| Penumbra, Inc. | 1 | $160 |
| Boston Scientific | 5 | $141 |
| Abiomed | 2 | $121 |
| Cashflow Solutions, LLC | 1 | $117 |
| Endologix LLC | 2 | $91 |
| Surmodics, Inc. | 3 | $57 |
| Johnson & Johnson | 1 | $29 |
| Reflow Medical Inc | 1 | $23 |
| Solventum Corporation | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Cagent Vascular Inc | 1 | $16 |
| Inari Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$4,925
- Endurant$2,500
- ENROUTE Transcarotid Neuroprotection System$597
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$486
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$299
- ENROUTE Transcarotid Stent$299
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$225
- GORE VIABAHN VBX Balloon Expandable Endo$196
- Indigo System$160
- Lympha Press Optimal Plus(US) BT$117
- PCD-51 731A (US) - White$117
- PCD-52 737A (US) White$117
How this compares
$9,969 in reported general payments places this provider in the 60th percentile of 35 vascular surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 11 | $358 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Oklahoma City
- Jim MeltonOklahoma City$131K
- Lenny StubbsOklahoma City$56K
- Ali AminOklahoma City$41K
- Bernardino RochaOklahoma City$34K
- Clifford HowellOklahoma City$17K
- Sherisa WarrenOklahoma City$15K
- Jones ThomasOklahoma City$14K
- Donald SpadoneOklahoma City$9K
- James NeelOklahoma City$7K
- Whitney ThorneOklahoma City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.